Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.Pinkal M. Desai,Janice Brown,Saar Gill,Melham M. Solh,Luke P. Akard,Jack W. Hsu,Celalettin Ustun,Charalambos Andreadis,Olga Frankfurt,James M. Foran,John Lister,Gary J. Schiller,Matthew J. Wieduwilt,John M. Pagel,Patrick J. Stiff,Delong Liu,Irum Khan,Wendy Stock,Suman Kambhampati,Martin S. Tallman,Lawrence Morris,John Edwards,Iskra Pusic,Hagop M. Kantarjian, Richard Mamelok,Alicia Wong,Rodney Van Syoc,Lois Kellerman,Swapna Panuganti, Ramkumar Mandalam,Camille N. Abboud,Farhad RavandiJournal of Clinical Oncology（2021）引用 8|浏览39AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
